{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:11:25Z","timestamp":1778850685053,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,15]]},"DOI":"10.7759\/cureus.108890","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T12:49:02Z","timestamp":1778849342000},"source":"Crossref","is-referenced-by-count":0,"title":["Treatment of Nodular Basal Cell Carcinoma With Topical 5% Imiquimod Cream: An Autobiographical Case Report"],"prefix":"10.7759","author":[{"given":"Philip R","family":"Cohen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-019-0610-0","article-title":"Diagnosis and management of basal cell carcinoma","volume":"20","author":"Tanese K","year":"2019","unstructured":"Tanese K. Diagnosis and management of basal cell carcinoma. Curr Treat Options Oncol. 2019, 20:13. 10.1007\/s11864-019-0610-0","journal-title":"Curr Treat Options Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.70050","article-title":"Japanese Dermatological Association Guidelines: clinical questions of guidelines for basal cell carcinoma 2025","volume":"53","author":"Hoashi T","year":"2026","unstructured":"Hoashi T, Ishikawa M, Uehara J, et al.. Japanese Dermatological Association Guidelines: clinical questions of guidelines for basal cell carcinoma 2025. J Dermatol. 2026, 53:e1-e14. 10.1111\/1346-8138.70050","journal-title":"J Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/CCO.0000000000001223","article-title":"Evolving paradigms in the management of basal cell carcinoma","volume":"38","author":"Palmisano G","year":"2026","unstructured":"Palmisano G, Traini DO, Brunetti F, Caponi F, D'Amore A, Di Stefani A. Evolving paradigms in the management of basal cell carcinoma. Curr Opin Oncol. 2026, 38:107-113. 10.1097\/CCO.0000000000001223","journal-title":"Curr Opin Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.113254","article-title":"European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023","volume":"192","author":"Peris K","year":"2023","unstructured":"Peris K, Fargnoli MC, Kaufmann R, et al.. European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023. Eur J Cancer. 2023, 192:113254. 10.1016\/j.ejca.2023.113254","journal-title":"Eur J Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.95556","article-title":"Curative or conservative approaches: a systematic review of surgical and nonsurgical treatments for basal cell carcinoma","volume":"17","author":"Sutrisno CSN","year":"2025","unstructured":"Sutrisno CSN, Pramita DH, Dewi IP. Curative or conservative approaches: a systematic review of surgical and nonsurgical treatments for basal cell carcinoma. Cureus. 2025, 17:e95556. 10.7759\/cureus.95556","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.14535","article-title":"Mohs micrographic surgery for basal cell carcinoma: predictive factors for increased stages and relative defect sizes","volume":"66","author":"Gnanendran S","year":"2025","unstructured":"Gnanendran S, Aghajani M, Elhindi J, Lee S, Bonilla GM. Mohs micrographic surgery for basal cell carcinoma: predictive factors for increased stages and relative defect sizes. Australas J Dermatol. 2025, 66:258-267. 10.1111\/ajd.14535","journal-title":"Australas J Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19743","article-title":"Efficacy of micrographic surgery versus conventional excision in reducing recurrence for basal cell carcinoma and squamous cell carcinoma: a systematic review and meta-analysis","volume":"38","author":"Lacerda PN","year":"2024","unstructured":"Lacerda PN, Lange EP, Luna NM, Miot HA, Abbade LP. Efficacy of micrographic surgery versus conventional excision in reducing recurrence for basal cell carcinoma and squamous cell carcinoma: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2024, 38:1058-1069. 10.1111\/jdv.19743","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13235","article-title":"Imiquimod in dermatology: an overview","volume":"55","author":"Hanna E","year":"2016","unstructured":"Hanna E, Abadi R, Abbas O. Imiquimod in dermatology: an overview. Int J Dermatol. 2016, 55:831-844. 10.1111\/ijd.13235","journal-title":"Int J Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200506030-00006","article-title":"Imiquimod: in superficial basal cell carcinoma","volume":"6","author":"Oldfield V","year":"2005","unstructured":"Oldfield V, Keating GM, Perry CM. Imiquimod: in superficial basal cell carcinoma. Am J Clin Dermatol. 2005, 6:195-200; discussion 201-202. 10.2165\/00128071-200506030-00006","journal-title":"Am J Clin Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16112135","article-title":"Topical and intralesional immunotherapy for the management of basal cell carcinoma","volume":"16","author":"Fern\u00e1ndez-Galv\u00e1n A","year":"2024","unstructured":"Fern\u00e1ndez-Galv\u00e1n A, Rodr\u00edguez-Jim\u00e9nez P, Gonz\u00e1lez-Sixto B, Abalde-Pintos MT, Butr\u00f3n-Bris B. Topical and intralesional immunotherapy for the management of basal cell carcinoma. Cancers (Basel). 2024, 16:2135. 10.3390\/cancers16112135","journal-title":"Cancers (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1638883","article-title":"Efficacy and safety of imiquimod 5% cream for basal cell carcinoma: a meta-analysis of randomized controlled trial","volume":"31","author":"Jia HX","year":"2020","unstructured":"Jia HX, He YL. Efficacy and safety of imiquimod 5% cream for basal cell carcinoma: a meta-analysis of randomized controlled trial. J Dermatolog Treat. 2020, 31:831-838. 10.1080\/09546634.2019.1638883","journal-title":"J Dermatolog Treat"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.09.033","article-title":"Five-year results of a randomized controlled trial comparing effectiveness of photodynamic therapy, topical imiquimod, and topical 5-fluorouracil in patients with superficial basal cell carcinoma","volume":"138","author":"Jansen MHE","year":"2018","unstructured":"Jansen MHE, Mosterd K, Arits AHMM, et al.. Five-year results of a randomized controlled trial comparing effectiveness of photodynamic therapy, topical imiquimod, and topical 5-fluorouracil in patients with superficial basal cell carcinoma. J Invest Dermatol. 2018, 138:527-533. 10.1016\/j.jid.2017.09.033","journal-title":"J Invest Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.11.021","article-title":"Treatment of low-risk basal cell\u00a0carcinoma","volume":"137","author":"Kelleners-Smeets NW","year":"2017","unstructured":"Kelleners-Smeets NW, Mosterd K, Nelemans PJ. Treatment of low-risk basal cell\u00a0carcinoma. J Invest Dermatol. 2017, 137:539-540. 10.1016\/j.jid.2016.11.021","journal-title":"J Invest Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13195730","article-title":"Immunotherapy in basal cell carcinoma","volume":"13","author":"Ungureanu L","year":"2024","unstructured":"Ungureanu L, Vasilovici AF, Halm\u00e1gyi SR, Trufin II, Apostu AP, Prisecaru M, \u0218enil\u0103 SC. Immunotherapy in basal cell carcinoma. J Clin Med. 2024, 13:5730. 10.3390\/jcm13195730","journal-title":"J Clin Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.9.1165","article-title":"Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens","volume":"138","author":"Shumack S","year":"2002","unstructured":"Shumack S, Robinson J, Kossard S, et al.. Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens. Arch Dermatol. 2002, 138:1165-1171. 10.1001\/archderm.138.9.1165","journal-title":"Arch Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-015-0024-0","article-title":"Imiquimod cream efficacy in the treatment of periocular nodular basal cell carcinoma: a non-randomized trial","volume":"15","author":"de Macedo EM","year":"2015","unstructured":"de Macedo EM, Carneiro RC, de Lima PP, Silva BG, Matayoshi S. Imiquimod cream efficacy in the treatment of periocular nodular basal cell carcinoma: a non-randomized trial. BMC Ophthalmol. 2015, 15:35. 10.1186\/s12886-015-0024-0","journal-title":"BMC Ophthalmol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.10.019","article-title":"Surgery versus 5% imiquimod for nodular\u00a0and superficial basal cell carcinoma: 5-year results of the SINS\u00a0randomized controlled trial","volume":"137","author":"Williams HC","year":"2017","unstructured":"Williams HC, Bath-Hextall F, Ozolins M, Armstrong SJ, Colver GB, Perkins W, Miller PSJ. Surgery versus 5% imiquimod for nodular\u00a0and superficial basal cell carcinoma: 5-year results of the SINS\u00a0randomized controlled trial. J Invest Dermatol. 2017, 137:614-619. 10.1016\/j.jid.2016.10.019","journal-title":"J Invest Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.05069.x","article-title":"Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion","volume":"147","author":"Sterry W","year":"2002","unstructured":"Sterry W, Ruzicka T, Herrera E, et al.. Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion. Br J Dermatol. 2002, 147:1227-1236. 10.1046\/j.1365-2133.2002.05069.x","journal-title":"Br J Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17132111","article-title":"Topical 5% imiquimod for the treatment of superficial and nodular periocular basal cell carcinoma: a systematic review of clinical outcomes, safety, and treatment strategies","volume":"17","author":"Krajewska-W\u0119glewicz L","year":"2025","unstructured":"Krajewska-W\u0119glewicz L, Sobolewski P, Walecka I. Topical 5% imiquimod for the treatment of superficial and nodular periocular basal cell carcinoma: a systematic review of clinical outcomes, safety, and treatment strategies. Cancers (Basel). 2025, 17:2111. 10.3390\/cancers17132111","journal-title":"Cancers (Basel)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-5945-12-19","article-title":"What determines patient preferences for treating low risk basal cell carcinoma when comparing surgery vs imiquimod? A discrete choice experiment survey from the SINS trial","volume":"12","author":"Tinelli M","year":"2012","unstructured":"Tinelli M, Ozolins M, Bath-Hextall F, Williams HC. What determines patient preferences for treating low risk basal cell carcinoma when comparing surgery vs imiquimod? A discrete choice experiment survey from the SINS trial. BMC Dermatol. 2012, 12:19. 10.1186\/1471-5945-12-19","journal-title":"BMC Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/493219-treatment-of-nodular-basal-cell-carcinoma-with-topical-5-imiquimod-cream-an-autobiographical-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T12:49:02Z","timestamp":1778849342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/493219-treatment-of-nodular-basal-cell-carcinoma-with-topical-5-imiquimod-cream-an-autobiographical-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.108890","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,15]]}}}